Back to List View Graph View

Luteolin

Luteolin is a naturally occurring flavone widely distributed in edible plants and medicinal herbs.

Where the papers sit

14 papers from the last 6 months study luteolin directly · updated from PubMed 9 Nov 2026

Study type 0 clinical trials · 14 preclinical

Themes one subject · 1 new direction

Those 14 are all about one subject.

  • Luteolin Therapeutic Applications

    Anticancer, antifibrotic, metabolic, and anti-inflammatory effects are being linked to defined pathways and improved delivery systems. Recurring mechanisms include NF-κB, PI3K/Akt, GLUT4, AKR1B1, and vascular smooth-muscle osteogenic signaling. Formulations using extracellular vesicles, composite gels, and emulsion gels aim to improve tissue targeting, solubility, and activity. Evidence remains predominantly preclinical, with efficacy shown across cell, animal, and extract-based studies rather than a unified clinical indication.

    14 papers

NEW DIRECTION

Luteolin is treated as an analytical measurand rather than a therapeutic agent

The Saraca asoca extract analytical-method study treats luteolin as one of four phytochemicals to be simultaneously quantified and validated by UV spectrophotometry and RP-HPLC, rather than as an intervention tested for a biological effect. This places luteolin in a measurement and quality-control role absent from the disease models, mechanistic studies, and delivery systems used elsewhere in the set, shifting the relevant question from what luteolin does biologically to how reliably its presence and amount can be established in extracts and formulations 42584238Aug.

luteolin chemical structure

Papers

The 14 papers from the last 6 months that study luteolin directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Luteolin Therapeutic Applications (14)
  1. Gossypetin and luteolin, alone and with cisplatin, preferentially reduce MCF-7 breast cancer cell viability, whereas HeLa cervical cancer cells are refractory. Molecular biology reports · 4 Nov 2026 PMID 42980935
  2. Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
  3. Deduhonghua-7 powder and its bioactive component luteolin alleviate hepatic fibrosis through CHRM3/NF-κB axis. Experimental cell research · 5 Sept 2026 PMID 42700788
  4. UV-Spectrophotometric and RP-HPLC Method Development and Validation for Simultaneous Estimation of Gallic Acid, Quercetin, Luteolin, and Apigenin in Saraca asoca Extract. Biomedical chromatography : BMC · 12 Aug 2026 PMID 42584238
  5. Unlocking native xanthan gum via succinylation to construct a hydrophilicity-driven O/W emulsion gel for enhanced luteolin delivery and pH-responsive release. International journal of biological macromolecules · 5 Aug 2026 PMID 42556676
  6. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
  7. Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study. Biochemical and biophysical research communications · 26 Jul 2026 PMID 42503269
  8. Shen-Gu-Mai-Kang Formula alleviates CKD-associated vascular calcification by suppressing VSMC osteogenic transdifferentiation via the Sfrp2/β-catenin signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497522
  9. Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism. Clinical & experimental metastasis · 14 Jul 2026 PMID 42446820
  10. Functionalized extracellular vesicles for enhanced brain targeted delivery of luteolin as a novel anti-neuroinflammatory therapy. International journal of pharmaceutics · 20 Jun 2026 PMID 42323031
  11. Enzymatic preparation of luteolin-rich olive (Olea europaea L.) leaf extract and its inhibitory effects on colitis. Bioorganic chemistry · 13 Jun 2026 PMID 42287884
  12. Luteolin from Lonicera japonica Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 13 Jun 2026 PMID 42287758
  13. Luteolin-Loaded WPI/Pueraria lobata Amylopectin Composite Gel Improves Adipocyte Thermogenesis and Insulin Sensitivity. ACS applied bio materials · 12 Jun 2026 PMID 42283235
  14. Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling, Antioxidant, Antibacterial, and Antidiabetic Properties of Fagonia cretica L.: Insights From In Vitro and In Silico Approaches. ChemistryOpen · 21 May 2026 PMID 42168772

By study type

Preclinical: animal, cell and lab studies (14)
  1. Gossypetin and luteolin, alone and with cisplatin, preferentially reduce MCF-7 breast cancer cell viability, whereas HeLa cervical cancer cells are refractory. Molecular biology reports · 4 Nov 2026 PMID 42980935
  2. Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
  3. Deduhonghua-7 powder and its bioactive component luteolin alleviate hepatic fibrosis through CHRM3/NF-κB axis. Experimental cell research · 5 Sept 2026 PMID 42700788
  4. UV-Spectrophotometric and RP-HPLC Method Development and Validation for Simultaneous Estimation of Gallic Acid, Quercetin, Luteolin, and Apigenin in Saraca asoca Extract. Biomedical chromatography : BMC · 12 Aug 2026 PMID 42584238
  5. Unlocking native xanthan gum via succinylation to construct a hydrophilicity-driven O/W emulsion gel for enhanced luteolin delivery and pH-responsive release. International journal of biological macromolecules · 5 Aug 2026 PMID 42556676
  6. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
  7. Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study. Biochemical and biophysical research communications · 26 Jul 2026 PMID 42503269
  8. Shen-Gu-Mai-Kang Formula alleviates CKD-associated vascular calcification by suppressing VSMC osteogenic transdifferentiation via the Sfrp2/β-catenin signaling. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497522
  9. Luteolin inhibits hyperglycemia-induced epithelial-mesenchymal transition and malignant progression in gastric cancer via targeting AKR1B1-mediated glucose metabolism. Clinical & experimental metastasis · 14 Jul 2026 PMID 42446820
  10. Functionalized extracellular vesicles for enhanced brain targeted delivery of luteolin as a novel anti-neuroinflammatory therapy. International journal of pharmaceutics · 20 Jun 2026 PMID 42323031
  11. Enzymatic preparation of luteolin-rich olive (Olea europaea L.) leaf extract and its inhibitory effects on colitis. Bioorganic chemistry · 13 Jun 2026 PMID 42287884
  12. Luteolin from Lonicera japonica Thunb. restores GLUT4-mediated glucose uptake via PI3K/Akt signaling in insulin resistance. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 13 Jun 2026 PMID 42287758
  13. Luteolin-Loaded WPI/Pueraria lobata Amylopectin Composite Gel Improves Adipocyte Thermogenesis and Insulin Sensitivity. ACS applied bio materials · 12 Jun 2026 PMID 42283235
  14. Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling, Antioxidant, Antibacterial, and Antidiabetic Properties of Fagonia cretica L.: Insights From In Vitro and In Silico Approaches. ChemistryOpen · 21 May 2026 PMID 42168772